Cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy: long-term follow up

Edgard Ferreira de Araújo1, Eduardo Gregório Chamlian2, Alexey Pomares Peroni2

  • 1Centro Cardiológico de Salinas, Salinas, MG, Brasil.

Insights

Cardiac resynchronization therapy significantly improves New York Heart Association class and survival in patients with Chagas cardiomyopathy and heart failure. This treatment offers a promising outcome for advanced disease stages.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Technology

Background:

  • Chagas disease is a significant cause of cardiomyopathy and sudden death.
  • High mortality is observed in patients with New York Heart Association (NYHA) class IV heart failure due to Chagas cardiomyopathy.

Purpose of the Study:

  • To analyze the clinical outcomes of patients with Chagas cardiomyopathy and congestive heart failure.
  • To evaluate the effectiveness of cardiac resynchronization therapy (CRT) combined with optimized pharmacological treatment.

Main Methods:

  • A cohort of 72 patients with Chagas cardiomyopathy (NYHA class III and IV) received CRT between 2004 and 2009.
  • Clinical evolution was monitored, and statistical analysis (t-test, Wilcoxon test) was performed with a significance level of P < 0.05.

Main Results:

  • After an average follow-up of 46.6 months, 87.4% of patients improved to NYHA class I or II (P<0.001).
  • Therapy response was observed in 65.3% of patients (P<0.001), with an overall mortality rate of 34.7%.

Conclusions:

  • Cardiac resynchronization therapy leads to significant improvements in NYHA class for chronic Chagas cardiomyopathy patients.
  • The therapy also resulted in increased left ventricle ejection fraction, reduced ventricular volumes, and improved patient survival.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
804
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
942
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
359